Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle
Open Access

Diagnostic Delay in Psoriatic Arthritis: A Population-based Study

Paras Karmacharya, Kerry Wright, Sara J. Achenbach, Delamo Bekele, Cynthia S. Crowson, Alexis Ogdie, Alí Duarte-García, Floranne C. Ernste, Megha M. Tollefson and John M. Davis III
The Journal of Rheumatology February 2021, jrheum.201199; DOI: https://doi.org/10.3899/jrheum.201199
Paras Karmacharya
This study was made possible using the resources of the Rochester Epidemiology Project, which is supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676, and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. PK is supported by T32 AR56950 grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program. ADG is supported by Centers for Disease Control and Prevention, the Rheumatology Research Foundation Scientist Development Award, the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, the Women’s Health Career Enhancement Award, and the Eaton Family Career Development Award. P. Karmacharya, MBBS, K. Wright, MBBS, D. Bekele, MBBS, F.C. Ernste, MD, J.M. Davis III, MD, MS, Division of Rheumatology, Mayo Clinic; S.J. Achenbach, MS, Department of Health Sciences Research, Mayo Clinic; C.S. Crowson, PhD, Division of Rheumatology, and Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; A. Ogdie, MD, MSCE, Departments of Medicine/Rheumatology and Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; A. Duarte-García, MD, MSc, Division of Rheumatology, and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic; M.M. Tollefson, MD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. AO has served as a consultant for AbbVie, Amgen, BMS, Celgene, Corrona, Janssen, Lilly, Novartis, and Pfizer (< $10,000 each), and has received grants from Novartis and Pfizer to Penn and from Amgen to Forward (grants > $10,000). JMD has received consulting fees and/or honoraria from AbbVie and Sanofi-Genzyme (< $10,000 each) and research support from Pfizer. No other disclosures are relevant to this article. Address correspondence to Dr. P. Karmacharya, Division of Rheumatology, Mayo Clinic College of Medicine, 200 First Street S.W., Rochester, MN 55905, USA. Email: paraskarmacharya@gmail.com. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication February 2, 2021.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paras Karmacharya
Kerry Wright
This study was made possible using the resources of the Rochester Epidemiology Project, which is supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676, and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. PK is supported by T32 AR56950 grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program. ADG is supported by Centers for Disease Control and Prevention, the Rheumatology Research Foundation Scientist Development Award, the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, the Women’s Health Career Enhancement Award, and the Eaton Family Career Development Award. P. Karmacharya, MBBS, K. Wright, MBBS, D. Bekele, MBBS, F.C. Ernste, MD, J.M. Davis III, MD, MS, Division of Rheumatology, Mayo Clinic; S.J. Achenbach, MS, Department of Health Sciences Research, Mayo Clinic; C.S. Crowson, PhD, Division of Rheumatology, and Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; A. Ogdie, MD, MSCE, Departments of Medicine/Rheumatology and Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; A. Duarte-García, MD, MSc, Division of Rheumatology, and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic; M.M. Tollefson, MD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. AO has served as a consultant for AbbVie, Amgen, BMS, Celgene, Corrona, Janssen, Lilly, Novartis, and Pfizer (< $10,000 each), and has received grants from Novartis and Pfizer to Penn and from Amgen to Forward (grants > $10,000). JMD has received consulting fees and/or honoraria from AbbVie and Sanofi-Genzyme (< $10,000 each) and research support from Pfizer. No other disclosures are relevant to this article. Address correspondence to Dr. P. Karmacharya, Division of Rheumatology, Mayo Clinic College of Medicine, 200 First Street S.W., Rochester, MN 55905, USA. Email: paraskarmacharya@gmail.com. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication February 2, 2021.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sara J. Achenbach
This study was made possible using the resources of the Rochester Epidemiology Project, which is supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676, and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. PK is supported by T32 AR56950 grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program. ADG is supported by Centers for Disease Control and Prevention, the Rheumatology Research Foundation Scientist Development Award, the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, the Women’s Health Career Enhancement Award, and the Eaton Family Career Development Award. P. Karmacharya, MBBS, K. Wright, MBBS, D. Bekele, MBBS, F.C. Ernste, MD, J.M. Davis III, MD, MS, Division of Rheumatology, Mayo Clinic; S.J. Achenbach, MS, Department of Health Sciences Research, Mayo Clinic; C.S. Crowson, PhD, Division of Rheumatology, and Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; A. Ogdie, MD, MSCE, Departments of Medicine/Rheumatology and Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; A. Duarte-García, MD, MSc, Division of Rheumatology, and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic; M.M. Tollefson, MD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. AO has served as a consultant for AbbVie, Amgen, BMS, Celgene, Corrona, Janssen, Lilly, Novartis, and Pfizer (< $10,000 each), and has received grants from Novartis and Pfizer to Penn and from Amgen to Forward (grants > $10,000). JMD has received consulting fees and/or honoraria from AbbVie and Sanofi-Genzyme (< $10,000 each) and research support from Pfizer. No other disclosures are relevant to this article. Address correspondence to Dr. P. Karmacharya, Division of Rheumatology, Mayo Clinic College of Medicine, 200 First Street S.W., Rochester, MN 55905, USA. Email: paraskarmacharya@gmail.com. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication February 2, 2021.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Delamo Bekele
This study was made possible using the resources of the Rochester Epidemiology Project, which is supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676, and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. PK is supported by T32 AR56950 grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program. ADG is supported by Centers for Disease Control and Prevention, the Rheumatology Research Foundation Scientist Development Award, the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, the Women’s Health Career Enhancement Award, and the Eaton Family Career Development Award. P. Karmacharya, MBBS, K. Wright, MBBS, D. Bekele, MBBS, F.C. Ernste, MD, J.M. Davis III, MD, MS, Division of Rheumatology, Mayo Clinic; S.J. Achenbach, MS, Department of Health Sciences Research, Mayo Clinic; C.S. Crowson, PhD, Division of Rheumatology, and Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; A. Ogdie, MD, MSCE, Departments of Medicine/Rheumatology and Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; A. Duarte-García, MD, MSc, Division of Rheumatology, and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic; M.M. Tollefson, MD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. AO has served as a consultant for AbbVie, Amgen, BMS, Celgene, Corrona, Janssen, Lilly, Novartis, and Pfizer (< $10,000 each), and has received grants from Novartis and Pfizer to Penn and from Amgen to Forward (grants > $10,000). JMD has received consulting fees and/or honoraria from AbbVie and Sanofi-Genzyme (< $10,000 each) and research support from Pfizer. No other disclosures are relevant to this article. Address correspondence to Dr. P. Karmacharya, Division of Rheumatology, Mayo Clinic College of Medicine, 200 First Street S.W., Rochester, MN 55905, USA. Email: paraskarmacharya@gmail.com. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication February 2, 2021.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cynthia S. Crowson
This study was made possible using the resources of the Rochester Epidemiology Project, which is supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676, and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. PK is supported by T32 AR56950 grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program. ADG is supported by Centers for Disease Control and Prevention, the Rheumatology Research Foundation Scientist Development Award, the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, the Women’s Health Career Enhancement Award, and the Eaton Family Career Development Award. P. Karmacharya, MBBS, K. Wright, MBBS, D. Bekele, MBBS, F.C. Ernste, MD, J.M. Davis III, MD, MS, Division of Rheumatology, Mayo Clinic; S.J. Achenbach, MS, Department of Health Sciences Research, Mayo Clinic; C.S. Crowson, PhD, Division of Rheumatology, and Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; A. Ogdie, MD, MSCE, Departments of Medicine/Rheumatology and Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; A. Duarte-García, MD, MSc, Division of Rheumatology, and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic; M.M. Tollefson, MD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. AO has served as a consultant for AbbVie, Amgen, BMS, Celgene, Corrona, Janssen, Lilly, Novartis, and Pfizer (< $10,000 each), and has received grants from Novartis and Pfizer to Penn and from Amgen to Forward (grants > $10,000). JMD has received consulting fees and/or honoraria from AbbVie and Sanofi-Genzyme (< $10,000 each) and research support from Pfizer. No other disclosures are relevant to this article. Address correspondence to Dr. P. Karmacharya, Division of Rheumatology, Mayo Clinic College of Medicine, 200 First Street S.W., Rochester, MN 55905, USA. Email: paraskarmacharya@gmail.com. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication February 2, 2021.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cynthia S. Crowson
Alexis Ogdie
This study was made possible using the resources of the Rochester Epidemiology Project, which is supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676, and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. PK is supported by T32 AR56950 grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program. ADG is supported by Centers for Disease Control and Prevention, the Rheumatology Research Foundation Scientist Development Award, the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, the Women’s Health Career Enhancement Award, and the Eaton Family Career Development Award. P. Karmacharya, MBBS, K. Wright, MBBS, D. Bekele, MBBS, F.C. Ernste, MD, J.M. Davis III, MD, MS, Division of Rheumatology, Mayo Clinic; S.J. Achenbach, MS, Department of Health Sciences Research, Mayo Clinic; C.S. Crowson, PhD, Division of Rheumatology, and Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; A. Ogdie, MD, MSCE, Departments of Medicine/Rheumatology and Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; A. Duarte-García, MD, MSc, Division of Rheumatology, and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic; M.M. Tollefson, MD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. AO has served as a consultant for AbbVie, Amgen, BMS, Celgene, Corrona, Janssen, Lilly, Novartis, and Pfizer (< $10,000 each), and has received grants from Novartis and Pfizer to Penn and from Amgen to Forward (grants > $10,000). JMD has received consulting fees and/or honoraria from AbbVie and Sanofi-Genzyme (< $10,000 each) and research support from Pfizer. No other disclosures are relevant to this article. Address correspondence to Dr. P. Karmacharya, Division of Rheumatology, Mayo Clinic College of Medicine, 200 First Street S.W., Rochester, MN 55905, USA. Email: paraskarmacharya@gmail.com. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication February 2, 2021.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alexis Ogdie
Alí Duarte-García
This study was made possible using the resources of the Rochester Epidemiology Project, which is supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676, and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. PK is supported by T32 AR56950 grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program. ADG is supported by Centers for Disease Control and Prevention, the Rheumatology Research Foundation Scientist Development Award, the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, the Women’s Health Career Enhancement Award, and the Eaton Family Career Development Award. P. Karmacharya, MBBS, K. Wright, MBBS, D. Bekele, MBBS, F.C. Ernste, MD, J.M. Davis III, MD, MS, Division of Rheumatology, Mayo Clinic; S.J. Achenbach, MS, Department of Health Sciences Research, Mayo Clinic; C.S. Crowson, PhD, Division of Rheumatology, and Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; A. Ogdie, MD, MSCE, Departments of Medicine/Rheumatology and Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; A. Duarte-García, MD, MSc, Division of Rheumatology, and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic; M.M. Tollefson, MD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. AO has served as a consultant for AbbVie, Amgen, BMS, Celgene, Corrona, Janssen, Lilly, Novartis, and Pfizer (< $10,000 each), and has received grants from Novartis and Pfizer to Penn and from Amgen to Forward (grants > $10,000). JMD has received consulting fees and/or honoraria from AbbVie and Sanofi-Genzyme (< $10,000 each) and research support from Pfizer. No other disclosures are relevant to this article. Address correspondence to Dr. P. Karmacharya, Division of Rheumatology, Mayo Clinic College of Medicine, 200 First Street S.W., Rochester, MN 55905, USA. Email: paraskarmacharya@gmail.com. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication February 2, 2021.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alí Duarte-García
Floranne C. Ernste
This study was made possible using the resources of the Rochester Epidemiology Project, which is supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676, and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. PK is supported by T32 AR56950 grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program. ADG is supported by Centers for Disease Control and Prevention, the Rheumatology Research Foundation Scientist Development Award, the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, the Women’s Health Career Enhancement Award, and the Eaton Family Career Development Award. P. Karmacharya, MBBS, K. Wright, MBBS, D. Bekele, MBBS, F.C. Ernste, MD, J.M. Davis III, MD, MS, Division of Rheumatology, Mayo Clinic; S.J. Achenbach, MS, Department of Health Sciences Research, Mayo Clinic; C.S. Crowson, PhD, Division of Rheumatology, and Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; A. Ogdie, MD, MSCE, Departments of Medicine/Rheumatology and Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; A. Duarte-García, MD, MSc, Division of Rheumatology, and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic; M.M. Tollefson, MD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. AO has served as a consultant for AbbVie, Amgen, BMS, Celgene, Corrona, Janssen, Lilly, Novartis, and Pfizer (< $10,000 each), and has received grants from Novartis and Pfizer to Penn and from Amgen to Forward (grants > $10,000). JMD has received consulting fees and/or honoraria from AbbVie and Sanofi-Genzyme (< $10,000 each) and research support from Pfizer. No other disclosures are relevant to this article. Address correspondence to Dr. P. Karmacharya, Division of Rheumatology, Mayo Clinic College of Medicine, 200 First Street S.W., Rochester, MN 55905, USA. Email: paraskarmacharya@gmail.com. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication February 2, 2021.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Megha M. Tollefson
This study was made possible using the resources of the Rochester Epidemiology Project, which is supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676, and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. PK is supported by T32 AR56950 grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program. ADG is supported by Centers for Disease Control and Prevention, the Rheumatology Research Foundation Scientist Development Award, the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, the Women’s Health Career Enhancement Award, and the Eaton Family Career Development Award. P. Karmacharya, MBBS, K. Wright, MBBS, D. Bekele, MBBS, F.C. Ernste, MD, J.M. Davis III, MD, MS, Division of Rheumatology, Mayo Clinic; S.J. Achenbach, MS, Department of Health Sciences Research, Mayo Clinic; C.S. Crowson, PhD, Division of Rheumatology, and Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; A. Ogdie, MD, MSCE, Departments of Medicine/Rheumatology and Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; A. Duarte-García, MD, MSc, Division of Rheumatology, and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic; M.M. Tollefson, MD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. AO has served as a consultant for AbbVie, Amgen, BMS, Celgene, Corrona, Janssen, Lilly, Novartis, and Pfizer (< $10,000 each), and has received grants from Novartis and Pfizer to Penn and from Amgen to Forward (grants > $10,000). JMD has received consulting fees and/or honoraria from AbbVie and Sanofi-Genzyme (< $10,000 each) and research support from Pfizer. No other disclosures are relevant to this article. Address correspondence to Dr. P. Karmacharya, Division of Rheumatology, Mayo Clinic College of Medicine, 200 First Street S.W., Rochester, MN 55905, USA. Email: paraskarmacharya@gmail.com. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication February 2, 2021.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John M. Davis III
This study was made possible using the resources of the Rochester Epidemiology Project, which is supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676, and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. PK is supported by T32 AR56950 grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program. ADG is supported by Centers for Disease Control and Prevention, the Rheumatology Research Foundation Scientist Development Award, the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, the Women’s Health Career Enhancement Award, and the Eaton Family Career Development Award. P. Karmacharya, MBBS, K. Wright, MBBS, D. Bekele, MBBS, F.C. Ernste, MD, J.M. Davis III, MD, MS, Division of Rheumatology, Mayo Clinic; S.J. Achenbach, MS, Department of Health Sciences Research, Mayo Clinic; C.S. Crowson, PhD, Division of Rheumatology, and Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; A. Ogdie, MD, MSCE, Departments of Medicine/Rheumatology and Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; A. Duarte-García, MD, MSc, Division of Rheumatology, and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic; M.M. Tollefson, MD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. AO has served as a consultant for AbbVie, Amgen, BMS, Celgene, Corrona, Janssen, Lilly, Novartis, and Pfizer (< $10,000 each), and has received grants from Novartis and Pfizer to Penn and from Amgen to Forward (grants > $10,000). JMD has received consulting fees and/or honoraria from AbbVie and Sanofi-Genzyme (< $10,000 each) and research support from Pfizer. No other disclosures are relevant to this article. Address correspondence to Dr. P. Karmacharya, Division of Rheumatology, Mayo Clinic College of Medicine, 200 First Street S.W., Rochester, MN 55905, USA. Email: paraskarmacharya@gmail.com. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication February 2, 2021.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John M. Davis III
  • Article
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 50, Issue 1
1 Jan 2023
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Diagnostic Delay in Psoriatic Arthritis: A Population-based Study
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Diagnostic Delay in Psoriatic Arthritis: A Population-based Study
Paras Karmacharya, Kerry Wright, Sara J. Achenbach, Delamo Bekele, Cynthia S. Crowson, Alexis Ogdie, Alí Duarte-García, Floranne C. Ernste, Megha M. Tollefson, John M. Davis
The Journal of Rheumatology Feb 2021, jrheum.201199; DOI: 10.3899/jrheum.201199

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Diagnostic Delay in Psoriatic Arthritis: A Population-based Study
Paras Karmacharya, Kerry Wright, Sara J. Achenbach, Delamo Bekele, Cynthia S. Crowson, Alexis Ogdie, Alí Duarte-García, Floranne C. Ernste, Megha M. Tollefson, John M. Davis
The Journal of Rheumatology Feb 2021, jrheum.201199; DOI: 10.3899/jrheum.201199
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • References
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • One-Third of European Patients with Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment
  • Oral Antiviral Treatment for COVID-19 in Patients With Systemic Autoimmune Rheumatic Diseases
  • The Positive Predictive Value of a Very High Serum IgG4 Concentration for the Diagnosis of IgG4-Related Disease
Show more Articles

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire